Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
The liver is a major metabolic organ and an immunologically complex organ. It produces and uses many substances such as acute phase proteins, cytokines, chemokines, and complementary components to maintain the balance between immunity and tolerance. Interleukins are important immune control cytokine...
Main Authors: | Su Yeon An, Anca D. Petrescu, Sharon DeMorrow |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.645703/full |
Similar Items
-
Interleukin-24 therapy- a potential new strategy against liver fibrosis
by: Anca D. Petrescu, et al.
Published: (2021-03-01) -
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
by: Arshi Khanam, et al.
Published: (2021-05-01) -
Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease
by: Anca D. Petrescu, et al.
Published: (2018-11-01) -
Activin B Promotes Hepatic Fibrogenesis
by: Wang, Yan
Published: (2019) -
Extracellular Vesicles From Hepatocytes Are Therapeutic for Toxin-Mediated Fibrosis and Gene Expression in the Liver
by: Xinlei Li, et al.
Published: (2020-01-01)